Antimicrobial consumption in the EU/EEA (ESAC-Net) - Annual Epidemiological Report 2025
Surveillance and monitoring
Progress towards the 2030 European Union (EU) antimicrobial consumption (AMC) targets improved in 2025 compared with previous years. There was a substantial reduction in overall consumption of antibacterials for systemic use (ATC J01) between 2024 and 2025, and a continued increase in the percentage of World Health Organization Access Watch Reserve (WHO AWaRe) Access group antimicrobials.
Key findings
Improved but insufficient progress towards the 2030 EU antimicrobial consumption targets
Despite this positive development, EU-level consumption is still not on track to achieve its targets by 2030. Key indicator results were as follows:
- The EU population-weighted mean consumption of antibacterials for systemic use (ATC J01) was 18.9 DDD per 1 000 inhabitants per day (DID) in 2025, representing a reduction of 1.0 DID (-5%) compared with the 2019 baseline. To achieve the EU-level target of 15.9 DID by 2030, a further reduction of 3.0 DID is required over the remaining five-year period (2026–2030).
- The EU population-weighted mean percentage of antimicrobial consumption for the WHO AWaRe Access group was 62.5% in 2025. This represents an increase of 1.4 percentage points compared with the 2019 baseline value of 61.1% but remains 2.5 percentage points below the 2030 target of at least 65%.
Publication file
Antimicrobial consumption in the EU/EEA (ESAC-Net) - Annual Epidemiological Report 2025
English (715.1 KB - PDF)Read the press release
Read about the campaign and see all the materials
External link
Related reports
Surveillance and monitoring